Please ensure Javascript is enabled for purposes of website accessibility
ホーム > サポート > フローラボノート&OMIPレビュー

Recombinant Protein Refolding from Inclusion Bodies: Protocol & Troubleshooting Guide

公開日: 2026-07-14  閲覧数: 134

E. coli remains the workhorse of recombinant protein production — fast growth, high yield, low cost, and well-established genetics make it the default choice for thousands of research-grade proteins. But there's a catch: many recombinant proteins expressed in E. coli form insoluble aggregates called inclusion bodies (IBs), especially large proteins, disulfide-bond-containing proteins, and membrane-associated targets.

Inclusion body formation isn't a failure — it's a feature. IBs contain highly concentrated, relatively pure target protein that can be solubilized and refolded into bioactive form. The challenge lies in the refolding step: choosing the right denaturant, managing the oxidation environment, and controlling aggregation. This guide provides a practical, step-by-step protocol for inclusion body isolation, solubilization, refolding, and quality assessment.

Why Do Inclusion Bodies Form in E. coli?

Inclusion bodies form when the rate of protein synthesis exceeds the capacity of the E. coli chaperone system to fold the polypeptide correctly. Several factors increase the likelihood of IB formation:

High expression level: Strong promoters (T7, tac) drive fast transcription, overwhelming the folding machinery.

Disulfide bonds: The reducing cytoplasm of E. coli cannot form disulfide bonds. Proteins requiring them (antibody fragments, growth factors, cytokines) misfold and aggregate.

Large or complex proteins: Multi-domain proteins and those with hydrophobic cores tend to aggregate before completing the folding pathway.

Absence of post-translational modifications: E. coli lacks the glycosylation machinery found in mammalian cells. Proteins that depend on glycosylation for stability may misfold.

High growth temperature: Expression at 37°C favors fast synthesis and IB formation. Lowering temperature to 16–25°C can improve soluble expression for some targets.

Refolding Workflow: From Inclusion Bodies to Bioactive Protein

The complete workflow involves four stages: cell lysis and IB isolation, solubilization in denaturant, refolding by controlled denaturant removal, and purification/quality assessment.

Step Stage Key Reagents Duration
1 Cell lysis & IB isolation Lysozyme, sonication, Triton X-100 wash 2–3 hours
2 Solubilization 6–8 M urea or 6 M GdnHCl + DTT 1–2 hours
3 Refolding Dilution/dialysis into refolding buffer + redox pair 12–48 hours
4 Purification & QC IMAC / SEC + SDS-PAGE + activity assay 4–6 hours

Step 1: Cell Lysis and Inclusion Body Isolation

The goal is to separate the dense, insoluble IBs from soluble E. coli proteins, nucleic acids, and cell debris.

Protocol

1. Resuspend the cell pellet from 1 L culture in 20–40 mL lysis buffer: 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mg/mL lysozyme, 1 mM PMSF. Incubate on ice for 30 min.

2. Sonicate on ice (6 × 30 s bursts, 30 s rest, 40% amplitude) until the lysate is no longer viscous. Alternatively, pass through a French press or microfluidizer at 15,000–20,000 psi.

3. Centrifuge at 15,000 × g for 20 min at 4°C. The pellet contains inclusion bodies. Save the supernatant to check soluble expression by SDS-PAGE.

4. Wash the IB pellet 2–3 times with wash buffer: 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 0.5% Triton X-100, 1 mM EDTA. This removes membrane debris and trapped soluble proteins. Centrifuge at 15,000 × g for 15 min between washes.

5. Final wash with Triton-free buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl) to remove residual detergent.

Tip: At this stage, IB pellets can be stored at −20°C for weeks. The washed IB pellet should appear white or off-white. A brown or gray color suggests incomplete removal of cell debris — add an additional wash step.

Step 2: Solubilization

IBs must be fully denatured before refolding. The choice of denaturant determines the completeness of unfolding and the ease of subsequent refolding.

Denaturant Comparison

Denaturant Working Conc. Pros Cons
Urea 6–8 M Mild; compatible with IMAC purification under denaturing conditions; easy to remove by dialysis May carbamylate proteins at high temperature or extended incubation; weaker denaturant than GdnHCl
Guanidine HCl (GdnHCl) 6 M Stronger denaturant; more complete unfolding; better for tightly aggregated IBs Incompatible with SDS-PAGE (precipitates SDS); higher cost; inhibits some downstream assays
Sarkosyl (N-lauroylsarcosine) 0.3–2% Mild; can solubilize some IBs without full denaturation; may preserve partial structure Not suitable for highly aggregated IBs; requires careful optimization

Protocol

1. Resuspend the washed IB pellet in solubilization buffer: 50 mM Tris-HCl pH 8.0, 6–8 M urea (or 6 M GdnHCl), 10 mM DTT (or 10 mM β-mercaptoethanol). Use 5–10 mL per gram of wet IB pellet.

2. Stir or rotate at room temperature for 1–2 hours until the solution is clear. If turbidity remains, centrifuge at 20,000 × g for 15 min and collect the supernatant.

3. Measure protein concentration by Bradford or BCA assay (dilute sample first to avoid denaturant interference). Adjust to 1–5 mg/mL for optimal refolding.

Critical: Fresh urea solutions should always be used or deionized with mixed-bed resin to remove cyanate ions. Cyanate modifies lysine residues (carbamylation) and can permanently inactivate your protein. Never heat urea solutions above 37°C.

Step 3: Refolding — The Critical Step

Refolding is the process of gradually removing the denaturant while allowing the protein to adopt its native conformation. This is where most refolding attempts fail — aggregation competes with productive folding, and the outcome depends heavily on protein concentration, buffer composition, temperature, and the rate of denaturant removal.

Refolding Methods Compared

Method Principle Best For Key Consideration
Rapid dilution Dilute denatured protein 10–50× into refolding buffer Simple proteins, initial screening Final protein conc. very low (20–100 µg/mL); large buffer volumes
Stepwise dialysis Gradually reduce denaturant by serial dialysis steps Disulfide-containing proteins, complex folds Slower but gentler; better for aggregation-prone proteins
On-column refolding Bind His-tagged protein to Ni-NTA under denaturing conditions, wash with decreasing urea gradient His-tagged proteins Protein immobilized on resin prevents aggregation; combines refolding + purification
Pulse renaturation Add small aliquots of denatured protein to refolding buffer over time Aggregation-prone proteins at scale Each pulse is diluted into already-folded protein; keeps unfolded concentration low

Refolding Buffer Composition

A typical refolding buffer contains four key components:

Component Concentration Purpose
Tris-HCl or PBS buffer 50 mM, pH 8.0–8.5 Maintains pH during folding
NaCl 100–500 mM Ionic strength stabilizes electrostatic interactions
Redox pair (GSH:GSSG) 1–5 mM GSH : 0.1–1 mM GSSG Enables disulfide bond shuffling for correct pairing
L-Arginine 0.4–0.8 M Suppresses aggregation without preventing folding; the single most effective additive
Glycerol or sucrose (optional) 5–15% Stabilizes folding intermediates; reduces aggregation

The #1 refolding rule: Keep the final protein concentration low — ideally 20–100 µg/mL. Aggregation is a concentration-dependent, second-order process. Doubling the protein concentration roughly quadruples the aggregation rate. If yield is a concern, use pulse renaturation or on-column refolding rather than increasing the protein concentration in a single dilution.

Rapid Dilution Protocol (Starting Point)

1. Prepare 500 mL of refolding buffer: 50 mM Tris-HCl pH 8.5, 240 mM NaCl, 10 mM KCl, 0.5 M L-arginine, 2 mM GSH, 0.2 mM GSSG.

2. Cool the refolding buffer to 4°C. Slow folding at low temperature reduces aggregation for most proteins.

3. While stirring gently, add the solubilized, denatured protein dropwise to achieve a final concentration of 50–100 µg/mL. For 5 mg of denatured protein at 1 mg/mL, add 5 mL into 500 mL of refolding buffer (1:100 dilution).

4. Continue gentle stirring at 4°C for 12–48 hours. Do not agitate vigorously — shear forces promote aggregation.

5. Remove any precipitate by centrifugation (15,000 × g, 20 min, 4°C) or filtration (0.45 µm).

6. Concentrate the refolded protein using an ultrafiltration device (Amicon, appropriate MWCO) and proceed to purification.

Step 4: Purification and Quality Assessment

After refolding, the sample contains a mixture of correctly folded protein, misfolded aggregates, and residual contaminants. Purification separates these species, and quality assessment confirms that the purified protein has the expected structure and activity.

Purification Strategy

IMAC (Ni-NTA): If your protein has a His-tag, IMAC purification after refolding is effective and fast. Bind in native buffer (no denaturant), wash with 20–40 mM imidazole, elute with 250–300 mM imidazole.

Size Exclusion Chromatography (SEC): SEC separates monomeric (correctly folded) protein from aggregates and truncated fragments. Run after IMAC for a polishing step. A sharp, symmetric monomer peak indicates successful refolding; a broad or left-shifted peak suggests aggregation.

Quality Assessment Checklist

Test Method Expected Result
Purity SDS-PAGE (reduced + non-reduced) Single band at expected MW; compare reduced vs. non-reduced for disulfide verification
Aggregation state SEC or DLS Monodisperse monomer peak; polydispersity < 20%
Secondary structure Circular Dichroism (CD) Spectrum consistent with expected fold (α-helix, β-sheet, or mixed)
Biological activity ELISA, cell-based assay, or binding assay Activity comparable to native or commercial reference standard
Endotoxin LAL assay < 1 EU/µg for cell-based assays; < 0.1 EU/µg for in vivo use

Troubleshooting Common Refolding Problems

Problem Likely Cause Solution
Heavy precipitation during refolding Protein concentration too high; refolding too fast Increase dilution ratio (1:50 → 1:100); reduce protein concentration to <50 µg/mL; add 0.5 M L-arginine; lower temperature to 4°C
Protein elutes in void volume on SEC Aggregated — not properly refolded Optimize redox pair ratio; try on-column refolding; switch from urea to GdnHCl for more complete denaturation before refolding
Correct MW on SDS-PAGE but no bioactivity Misfolded; incorrect disulfide pairing Adjust GSH:GSSG ratio (try 5:1, 10:1, 1:1); slow down refolding with stepwise dialysis; add chaperones (GroEL/ES)
Low yield after refolding Most protein aggregated and removed by centrifugation Use pulse renaturation to keep unfolded protein concentration low; add 5–10% glycerol; try on-column refolding
Multiple bands on non-reduced SDS-PAGE Intermolecular disulfide bonds (aggregates) Increase GSH concentration; ensure complete reduction during solubilization; add 1–2 mM EDTA to chelate metal ions that catalyze oxidation

When to Refold vs. When to Buy: A Practical Decision Framework

Refolding is a powerful technique, but it's also time-consuming and has an inherent failure rate. Before committing to refolding, consider whether purchasing a ready-made recombinant protein is more efficient for your experimental timeline.

Scenario Recommendation
You need a standard cytokine, growth factor, or receptor ECD for ELISA or WB Buy — abinScience offers 11,900+ E. coli-expressed recombinant proteins with verified purity and lot-to-lot consistency
You need a custom mutant, truncation, or fusion protein not commercially available Refold — this guide helps you optimize the process
You need large quantities (>10 mg) for in vivo or structural studies Consider refolding for cost efficiency, or request a bulk quote from abinScience
You need bioactive, properly glycosylated protein Use mammalian-expressed protein instead — E. coli refolding cannot restore glycosylation

Frequently Asked Questions

What is the typical refolding yield?
Refolding yields vary widely depending on the protein — 5–30% is typical for a first attempt. Well-optimized protocols for established targets can reach 50–80%. The main losses come from aggregation during the refolding step.

Can I refold a protein without a His-tag?
Yes, but purification after refolding becomes more challenging. Without a His-tag, you'll need to use ion exchange chromatography (IEX) or hydrophobic interaction chromatography (HIC) instead of IMAC. On-column refolding also requires an affinity tag.

Does the His-tag affect refolding?
Generally no — a 6×His tag is small (0.84 kDa) and usually doesn't interfere with folding. It can be removed post-purification using TEV or 3C protease if needed for functional studies.

Why is L-arginine so effective at preventing aggregation?
L-arginine interacts with partially folded intermediates through a combination of hydrogen bonding, electrostatic interactions, and mild chaotropic effects. It increases the solubility of folding intermediates without destabilizing the native state, effectively widening the window between productive folding and aggregation.

Need a Ready-Made Recombinant Protein Instead?

abinScience offers 11,900+ E. coli-expressed and 4,700+ mammalian-expressed recombinant proteins — most with His-tag, GST-tag, or Fc-fusion options. Skip the refolding and get verified, lot-consistent protein delivered.

Browse Recombinant Proteins →

References

  1. Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng. 2005;99(4):303-310. doi: 10.1263/jbb.99.303
  2. Yamaguchi H, Miyazaki M. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies. Biomolecules. 2014;4(1):235-251. doi: 10.3390/biom4010235
  3. Tsumoto K, et al. Role of arginine in protein refolding, solubilization, and purification. Biotechnol Prog. 2004;20(5):1301-1308. doi: 10.1021/bp0498793
  4. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol. 2004;22(11):1399-1408. doi: 10.1038/nbt1029
レコメンデーション

無料クォート取得